| Interactions of potential anti-COVID-19 compounds with multispecific ABC and OATP drug transporters Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... Pharmaceutics 13 (1), 81, 2021 | 42 | 2021 |
| Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter B Zámbó, O Mózner, Z Bartos, G Török, G Várady, Á Telbisz, L Homolya, ... Cellular and Molecular Life Sciences 77, 365-378, 2020 | 28 | 2020 |
| Cellular processing of the ABCG2 transporter—Potential effects on gout and drug metabolism O Mózner, Z Bartos, B Zámbó, L Homolya, T Hegedűs, B Sarkadi Cells 8 (10), 1215, 2019 | 28 | 2019 |
| Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression B Zámbó, Z Bartos, O Mózner, E Szabó, G Várady, G Poór, M Pálinkás, ... Scientific reports 8 (1), 7487, 2018 | 27 | 2018 |
| Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes E Szabó, A Kulin, O Mózner, L Korányi, B Literáti-Nagy, M Vitai, ... PLoS One 16 (12), e0260957, 2021 | 9 | 2021 |
| Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia M Pálinkás, E Szabó, A Kulin, O Mózner, R Rásonyi, P Juhász, K Nagy, ... Clinical and Experimental Medicine 23 (4), 1277-1284, 2023 | 8 | 2023 |
| Modulation of the human erythroid plasma membrane calcium pump (PMCA4b) expression by polymorphic genetic variants O Mózner, B Zámbó, B Sarkadi Membranes 11 (8), 586, 2021 | 5 | 2021 |
| Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 13 Á Telbisz, C Ambrus, O Mózner | 5 | 2021 |
| Interactions of anti-COVID-19 drug candidates with multispecific ABC and OATP drug transporters Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... bioRxiv, 2020.11. 21.392555, 2020 | 5 | 2020 |
| Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency L Broca-Brisson, R Harati, C Disdier, O Mozner, R Gaston-Breton, ... Elife 12, RP88459, 2023 | 2 | 2023 |
| The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19 H Papp, E Tóth, J Bóvári‐Biri, K Bánfai, P Juhász, M Mahdi, LC Russo, ... British Journal of Pharmacology, 2024 | 1 | 2024 |
| Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus Variants O Mózner, J Moldvay, KS Szabó, D Vaskó, J Domján, D Ács, Z Ligeti, ... Biomedicines 11 (12), 3193, 2023 | 1 | 2023 |
| Raman and NIR spectroscopy-based real-time monitoring of the membrane filtration process of a recombinant protein for the diagnosis of SARS-CoV2 D Vaskó, E Pantea, J Domján, C Fehér, O Mózner, B Sarkadi, ZK Nagy, ... International Journal of Pharmaceutics, 124251, 2024 | | 2024 |
| Identification and quantitative characterization of protein-DNA interactions with the native holdup assay: GATA1 regulation of the plasma membrane calcium pump B Zambo, B Morlet, L Negroni, O Mozner, B Sarkadi, G Trave, G Gogl bioRxiv, 2024.08. 26.609639, 2024 | | 2024 |
| Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity O Mozner, E Szabo, A Kulin, G Varady, J Moldvay, V Vass, A Szentesi, ... medRxiv, 2024.03. 13.24304197, 2024 | | 2024 |
| Application of an Rbd-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus Variants O Mózner, J Moldvay, KS Szabó, D Vaskó, J Domján, D Ács, Z Ligeti, ... Preprints, 2023 | | 2023 |
| Expression, Function and Trafficking of the Human ABCG2 Multidrug Transporter Containing Mutations in an Unstructured Cytoplasmic Loop O Mózner, B Zámbó, Z Bartos, A Gergely, KS Szabó, B Jezsó, Á Telbisz, ... Membranes 13 (10), 822, 2023 | | 2023 |
| Rucaparib blocks SARS-CoV-2 virus binding to cells and interleukin-6 release in a model of COVID-19 H Papp, J Bóvári-Biri, K Bánfai, P Juhász, M Mahdi, LC Russo, D Bajusz, ... medRxiv, 2022.06. 30.22277079, 2022 | | 2022 |
| Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters. Pharmaceutics 2021, 13, 81 Á Telbisz, C Ambrus, O Mózner, E Szabó, G Várady, É Bakos, B Sarkadi, ... s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2021 | | 2021 |
| Characterization of a newly identified polymorphic variant (M71V) of ABCG2 multidrug transporter L Homolya, Z Bartos, B Zambo, O Mozner, B Sarkadi The FASEB Journal 33 (S1), 462.2-462.2, 2019 | | 2019 |
